Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Thoughts and concerns

<< Previous

Bullboard Posts

Next >>

Comment by Gorf79on Jun 30, 2022 1:31pm

198 Views

Post# 34794378

RE:Thoughts and concerns

Yeah 34 cents is a joke.

That translates to roughly a 100 mil US market cap.

I'd be willing to bet that the ARC deal alone crests 100 mil USD within 18 months of installations.

Some very light research tells you that across 7 US States ARC's network and dialysis site installations are nothing short of Monstrous!

Alas, it is Spectral and a fair valuation is 34 cents Canadian......

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity